These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 27770867)
1. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. Krupkova O; Ferguson SJ; Wuertz-Kozak K J Nutr Biochem; 2016 Nov; 37():1-12. PubMed ID: 27770867 [TBL] [Abstract][Full Text] [Related]
2. Encapsulation of (-)-epigallocatechin gallate into liposomes and into alginate or chitosan microparticles reinforced with liposomes. Istenič K; Cerc Korošec R; Poklar Ulrih N J Sci Food Agric; 2016 Oct; 96(13):4623-32. PubMed ID: 26921243 [TBL] [Abstract][Full Text] [Related]
3. Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate. Fangueiro JF; Parra A; Silva AM; Egea MA; Souto EB; Garcia ML; Calpena AC Int J Pharm; 2014 Nov; 475(1-2):181-90. PubMed ID: 25175728 [TBL] [Abstract][Full Text] [Related]
4. Production of monodisperse epigallocatechin gallate (EGCG) microparticles by spray drying for high antioxidant activity retention. Fu N; Zhou Z; Jones TB; Tan TT; Wu WD; Lin SX; Chen XD; Chan PP Int J Pharm; 2011 Jul; 413(1-2):155-66. PubMed ID: 21554936 [TBL] [Abstract][Full Text] [Related]
6. Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles. Tyagi N; De R; Begun J; Popat A Int J Pharm; 2017 Feb; 518(1-2):220-227. PubMed ID: 27988378 [TBL] [Abstract][Full Text] [Related]
7. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage. Minnelli C; Moretti P; Fulgenzi G; Mariani P; Laudadio E; Armeni T; Galeazzi R; Mobbili G Int J Pharm; 2018 Dec; 552(1-2):225-234. PubMed ID: 30291957 [TBL] [Abstract][Full Text] [Related]
8. Preservation of (-)-epigallocatechin-3-gallate antioxidant properties loaded in heat treated β-lactoglobulin nanoparticles. Li B; Du W; Jin J; Du Q J Agric Food Chem; 2012 Apr; 60(13):3477-84. PubMed ID: 22409289 [TBL] [Abstract][Full Text] [Related]
9. Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. Proniuk S; Liederer BM; Blanchard J J Pharm Sci; 2002 Jan; 91(1):111-6. PubMed ID: 11782902 [TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420 [TBL] [Abstract][Full Text] [Related]
11. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation. Frias I; Neves AR; Pinheiro M; Reis S Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems. Granja A; Frias I; Neves AR; Pinheiro M; Reis S Biomed Res Int; 2017; 2017():5813793. PubMed ID: 28791306 [TBL] [Abstract][Full Text] [Related]
13. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272 [TBL] [Abstract][Full Text] [Related]
14. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Hong J; Lu H; Meng X; Ryu JH; Hara Y; Yang CS Cancer Res; 2002 Dec; 62(24):7241-6. PubMed ID: 12499265 [TBL] [Abstract][Full Text] [Related]
15. Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization. Bianchi A; Marchetti N; Scalia S J Pharm Biomed Anal; 2011 Dec; 56(4):692-7. PubMed ID: 21807473 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of different co-antioxidants on the photochemical- and functional-stability of epigallocatechin-3-gallate in topical creams exposed to simulated sunlight. Scalia S; Marchetti N; Bianchi A Molecules; 2013 Jan; 18(1):574-87. PubMed ID: 23292326 [TBL] [Abstract][Full Text] [Related]
17. Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions. Liang R; Chen L; Yokoyama W; Williams PA; Zhong F J Agric Food Chem; 2016 Dec; 64(48):9180-9188. PubMed ID: 27933988 [TBL] [Abstract][Full Text] [Related]
18. Protonation of epigallocatechin-3-gallate (EGCG) results in massive aggregation and reduced oral bioavailability of EGCG-dispersed selenium nanoparticles. Wu S; Sun K; Wang X; Wang D; Wan X; Zhang J J Agric Food Chem; 2013 Jul; 61(30):7268-75. PubMed ID: 23822637 [TBL] [Abstract][Full Text] [Related]
19. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. Dube A; Nicolazzo JA; Larson I Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598 [TBL] [Abstract][Full Text] [Related]
20. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. Sang S; Lee MJ; Hou Z; Ho CT; Yang CS J Agric Food Chem; 2005 Nov; 53(24):9478-84. PubMed ID: 16302765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]